Company intelligence
Ebenbuild
Personalized health intelligence for the lung
About Ebenbuild
Ebenbuild is a digital health tech pioneer developing precise, patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. Its digital toolset is based on physics-based simulation, AI, and data science and is designed to support decision makers in the life sciences industry, clinicians, and physicians. Ebenbuild's approach provides a better understanding of respiratory diseases and individual pathophysiology enabling a new class of products and services ranging from in silico trials to accelerate and de-risk the development of inhaled drugs to personalized treatment options that improve the chances of survival and recovery in millions of cases of respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS) each year.
Verified activity
Signals from Ebenbuild
2 published signals
Products & Services
Ebenbuild used Twinhale, an in silico trials platform built on high-fidelity whole-lung models, to support AP01 modeling work for Avalyn Pharma at the ERS2026 conference.
Reported by Ebenbuild
Presence & Recognition
Ebenbuild is attending the 9th International Conference on the Virtual Physiological Human at VPH - The Society for In Silico Medicine 2026 in Milan this week, alongside CTO Jonas Biehler.
Reported by Ebenbuild